companydata.dkcompanydata.dk

PULMOPHARMA ApS: Financial statements 2021

CVR: 36428023

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

PULMOPHARMA ApS (CVR 36428023) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -80,380 and a net result of DKK -93,103 compared with DKK -18,958 the year before. Equity in the 2021 report amounted to DKK 3,511,715. The solvency ratio was 88.1%.

Gross Profit
DKK -80,380
Profit/Loss
DKK -93,103
Equity
DKK 3,511,715
Total Assets
DKK 3,986,517
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--80 t.-93 t.3.5 mio.0
2020--1 t.-19 t.-395 t.1
2019--9 t.-26 t.-376 t.-
2018--292 t.-224 t.-350 t.-
2017--120 t.-123 t.-126 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PULMOPHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

PULMOPHARMA IVS changes name to PULMOPHARMA ApSOct 1, 2021

On October 1, 2021, the company changed its name from PULMOPHARMA IVS to PULMOPHARMA ApS.

PULMOPHARMA ApS: The 2020 annual report is outJun 30, 2021

PULMOPHARMA ApS has published its annual report for 2020. Gross profit came to DKK -1,060, and the net result was DKK -18,958.

Per Bendix Jeppesen joins the board of PULMOPHARMA ApSMay 28, 2021

As of May 28, 2021, Per Bendix Jeppesen has joined the board of directors of PULMOPHARMA ApS.

Dan Mønster Nielsen joins the board of PULMOPHARMA ApSMay 28, 2021

As of May 28, 2021, Dan Mønster Nielsen has joined the board of directors of PULMOPHARMA ApS.

Peter Frithjof Bang joins the board of PULMOPHARMA ApSMay 28, 2021

As of May 28, 2021, Peter Frithjof Bang has joined the board of directors of PULMOPHARMA ApS.

Torben Ballegaard Sørensen joins the board of PULMOPHARMA ApSMay 28, 2021

As of May 28, 2021, Torben Ballegaard Sørensen has joined the board of directors of PULMOPHARMA ApS.

About PULMOPHARMA ApS

PULMOPHARMA ApS is a Danish company of the type Anpartsselskab based in Ebeltoft, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PULMOPHARMA IVS. The management consists of Dan Mønster Nielsen. The board consists of Torben Ballegaard Sørensen (chair), Dan Mønster Nielsen, Per Bendix Jeppesen and Peter Frithjof Bang. The company's owners include PETER BANG HOLDING ApS, LARS NYENSTAD ApS and BENDIX-HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity in the 2025 report amounted to DKK 11,436,934.

Source: annual report 2025, Danish Business Authority